Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings

CHE, HCTT

Title: Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings

Full Record
Other Related Research

Abstract

The purpose of this document is to provide guidance for planning and conducting 2009 H1N1 Influenza vaccination of pediatric patients in private healthcare settings.

Authors:: CHE, HCTT

Publication Date:: Fri Jan 01 00:00:00 EST 2010

Research Org.:: Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States)

Sponsoring Org.:: Work for Others- CDC DHQP

OSTI Identifier:: 1004392

Report Number(s):: 10-HCTT-1898
TRN: US201103%%534

DOE Contract Number:: DE-AC05-06OR23100

Resource Type:: Conference

Country of Publication:: United States

Language:: English

Subject:: 99 GENERAL AND MISCELLANEOUS; INFLUENZA; PATIENTS; PEDIATRICS; PLANNING; pandemic influenza preparedness

Citation Formats


                    CHE, HCTT. Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings.  United States: N. p., 2010. 
        Web.

Copy to clipboard


                    CHE, HCTT. Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings.  United States.

Copy to clipboard


                    CHE, HCTT. 2010.  
        "Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings".  United States.  https://www.osti.gov/servlets/purl/1004392.

Copy to clipboard


                    
@article{osti_1004392,

  title        = {Planning Guide for Vaccinating Pediatric Patients Against H1N1 Influenza in Private Healthcare Settings},

  author       = {CHE, HCTT},

  abstractNote = {The purpose of this document is to provide guidance for planning and conducting 2009 H1N1 Influenza vaccination of pediatric patients in private healthcare settings.},

  doi          = {},

  url          = {https://www.osti.gov/biblio/1004392},
  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {Fri Jan 01 00:00:00 EST 2010},

  month        = {Fri Jan 01 00:00:00 EST 2010}

}

Copy to clipboard

Conference:

View Conference (1.76 MB)

Other availability

Please see Document Availability for additional information on obtaining the full-text document. Library patrons may search WorldCat to identify libraries that hold this conference proceeding.

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Pediatric Healthcare Response to Pandemic (H1N1) 2009 Influenza Stakeholder Meeting - Summary of Proceedings

Conference CHE, HCTT

The goal of the meeting was to bring together subject matter experts to develop tools and resources for use by the pediatric healthcare community in response to 2009 (H1N1) pandemic influenza activity during the 2009 influenza season.
Full Text Available
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient

Journal Article Hu, Weibin; Chen, Aizhong; Miao, Yi; ... - Virology

Whether the 2009 pandemic H1N1 influenza vaccine can induce heterosubtypic cross-protective anti-hemagglutinin (HA) neutralizing antibodies is an important issue. We obtained a panel of fully human monoclonal antibodies from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient. Most of the monoclonal antibodies targeted the HA protein but not the HA1 fragment. Among the analyzed antibodies, seven mAbs exhibited neutralizing activity against several influenza A viruses of different subtypes. The conserved linear epitope targeted by the neutralizing mAbs (FIEGGWTGMVDGWYGYHH) is part of the fusion peptide on HA2. Our work suggests that a heterosubtypic neutralizing antibody response primarilymore »« less
https://doi.org/10.1016/J.VIROL.2012.09.034
Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs

Journal Article Kimble, J.; Wymore Brand, Meghan; Kaplan, Bryan; ... - Journal of Virology

Influenza A virus (IAV) causes respiratory disease in swine and humans. Vaccines are used to prevent influenza illness in both populations but must be frequently updated due to rapidly evolving strains. Mismatch between the circulating strains and the strains contained in vaccines may cause loss of efficacy. Whole inactivated virus (WIV) vaccines with adjuvant, utilized by the swine industry, are effective against antigenically similar viruses; however, vaccine-associated enhanced respiratory disease (VAERD) may happen when the WIV is antigenically mismatched with the infecting virus. VAERD is a repeatable model in pigs, but had yet to be experimentally demonstrated in other mammalianmore »« less
https://doi.org/10.1128/jvi.01725-21

Full Text Available
Reverse-zoonoses of 2009 H1N1 pandemic influenza A viruses and evolution in United States swine results in viruses with zoonotic potential

Journal Article Markin, Alexey; Ciacci Zanella, Giovana; Arendsee, Zebulun; ... - PLoS Pathogens

The 2009 H1N1 pandemic (pdm09) lineage of influenza A virus (IAV) crosses interspecies barriers with frequent human-to-swine spillovers each year. These spillovers reassort and drift within swine populations, leading to genetically and antigenically novel IAV that represent a zoonotic threat. We quantified interspecies transmission of the pdm09 lineage, persistence in swine, and identified how evolution in swine impacted zoonotic risk. Human and swine pdm09 case counts between 2010 and 2020 were correlated and human pdm09 burden and circulation directly impacted the detection of pdm09 in pigs. However, there was a relative absence of pdm09 circulation in humans during the 2020–21more »« less
https://doi.org/10.1371/journal.ppat.1011476
Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice

Journal Article Wang, Jiqin; Liu, Mei; Ding, Nianchang; ... - Biochemical and Biophysical Research Communications

Antibody-dependent cell-mediated cytotoxicity bridges humoral immunity and cellular immunity. Thus vaccine candidates which can elicit both broadly neutralizing antibodies and potent antibody-dependent cell-mediated cytotoxicity (ADCC) are recommended. Previously, a panel of functional epitopes that can elicit ADCC effects is isolated and characterized on the H1N1 Influenza Virus. Based on these identified epitopes, an epitope vaccine against H1N1 infection has been designed. The serum of vaccine immunized mice show potent ADCC activities in comparison with vector control group and HA ecto domain vaccinated group. However, the release of IL-6 and TNFα is higher in lung of epitope vaccine immunized mice. Themore »« less
https://doi.org/10.1016/J.BBRC.2018.07.129

Similar Records